Back to Newsroom
Back to Newsroom

CLASS ACTION UPDATE for LX, C and GOCO: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Monday, 09 November 2020 07:30 AM

Levi & Korsinsky, LLP

Topic:
Lawsuits

NEW YORK, NY / ACCESSWIRE / November 9, 2020 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.

LX Shareholders Click Here: https://www.zlk.com/pslra-1/lexinfintech-holdings-ltd-information-request-form?prid=10789&wire=1
C Shareholders Click Here: https://www.zlk.com/pslra-1/citigroup-inc-information-request-form?prid=10789&wire=1
GOCO Shareholders Click Here: https://www.zlk.com/pslra-1/gohealth-inc-information-request-form?prid=10789&wire=1

* ADDITIONAL INFORMATION BELOW *

Lexinfintech Holdings, Ltd. (NASDAQ:LX)

This lawsuit is on behalf of shareholders who purchased or otherwise acquired: (a) Lexin American depositary shares pursuant and/or traceable to the Company's initial public offering conducted on or about December 21, 2017; or (b) Lexin securities between December 21, 2017 and August 24, 2020.
Lead Plaintiff Deadline : November 9, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/lexinfintech-holdings-ltd-information-request-form?prid=10789&wire=1

According to the filed complaint, (1) LexinFintech reported artificially low delinquency rates by giving borrowers in default new funds to make payments; (2) the Company's business model exposes shareholders to enormous losses by prioritizing Chinese lenders for off-balance sheet loans; (3) the Company exaggerated its user base; (4) the Company was facilitating direct peer to peer lending contrary to Chinese law; (5) the Company engaged in undisclosed related party transactions; (6) the Company lacked adequate internal controls; and (7) as a result, Defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Citigroup Inc. (NYSE:C)

C Lawsuit on behalf of: investors who purchased February 25, 2017 - October 12, 2020
Lead Plaintiff Deadline : December 29, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/citigroup-inc-information-request-form?prid=10789&wire=1

According to the filed complaint, throughout the class period, defendants willfully or recklessly made and/or caused the Company to make false and misleading statements regarding Citi's internal controls and risk management capabilities that failed to disclose the serious and longstanding inadequacy of Citi's internal controls, data governance, compliance risk management, and enterprise risk management. As a result, Defendants' statements about Citi's internal controls and risk management were materially false and/or misleading and/or lacked a reasonable basis.

GoHealth, Inc. (NASDAQ:GOCO)

The GoHealth lawsuit is on behalf of all purchasers of GoHealth Class A common stock pursuant and/or traceable to the registration statement issued in connection with GoHealth's July 2020 initial public offering.
Lead Plaintiff Deadline : November 20, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/gohealth-inc-information-request-form?prid=10789&wire=1

According to the filed complaint, (i) the Medicare insurance industry was undergoing a period of elevated churn, which had begun in the first half of 2020; (ii) GoHealth suffered from a higher risk of customer churn as a result of its unique business model and limited carrier base; (iii) GoHealth suffered from degradations in customer persistency and retention as a result of elevated industry churn, vulnerabilities that arose from the Company's concentrated carrier business model, and GoHealth's efforts to expand into new geographies, develop new carrier partnerships and worsening product mix; (iv) GoHealth had entered into materially less favorable revenue sharing arrangements with its external sales agents; and (v) these adverse financial and operational trends were internally projected by GoHealth to continue and worsen following the initial public offering.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP

Topic:
Lawsuits
Back to newsroom
Back to Newsroom
Share by: